CHI3L1 and neoplasm: In particular, in cancer-related inflammatory responses, CHI3L1 promotes tumor cell proliferation, migration, and immune evasion by binding to specific receptors (e.g., IL-13Rα2, CD44) and activating downstream signaling pathways (e.g., MAPK, PI3K/AKT) (18, 19).